Skip to main content

Advertisement

Log in

Synthesis and antimicrobial activity of some (3-phenyl-5-(1-phenyl-3-aryl-1H-pyrazol-4-yl)-4,5-dihydro-1H-pyrazol-1-yl)(pyridin-4-yl)methanones: new derivatives of 1,3,5-trisubstituted pyrazolines

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

A series of (3-phenyl-5-(1-phenyl-3-aryl-1H-pyrazol-4-yl)-4,5-dihydro-1H-pyrazol-1-yl)(pyridin-4-yl)methanones was synthesized by condensing suitably substituted chalcones, i.e., 3-(3-aryl-1-phenyl-1H-pyrazol-4-yl)-1-phenylprop-2-en-1-ones, and isoniazid in acetic acid. The structure of newly synthesized compounds has been established on the basis of analytical and spectral data. The new compounds were screened for antimicrobial activity and most of them showed good activity comparable with that of standard drugs ciprofloxacin and fluconazole. Compounds containing methoxy group showed high antimicrobial activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Scheme 1
Fig. 1

Similar content being viewed by others

References

  • Abdel-Hafez ESMN, Abuo-Rahma G, El-D AA, Abdel-Aziz M, Radwan MF, Farag HH (2009) Design, synthesis and biological investigation of certain pyrazole-3-carboxylic acid derivatives as novel carriers for nitric oxide. Bioorg Med Chem 17:3829–3837

    Article  CAS  Google Scholar 

  • Acharya BN, Saraswat D, Tiwari M, Shrivastava AK, Ghorpade R, Bapna S, Kaushik MP (2010) Synthesis and antimalarial evaluation of 1,3,5-trisubstituted pyrazolines. Eur J Med Chem 45:430–438

    Article  PubMed  CAS  Google Scholar 

  • Ali MA, Shaharyar M, Siddiqui AA, Sriram D, Yogeeswari P, Clercq ED (2007) Synthesis and anti-HIV activity of N1-nicotinoyl-3-(4′-hydroxy-3′-methylmrthylphenyl)-5-[substituted phenyl]-2-pyrazolones. Acta Pol Pharma Drug Res 63:435–439

    Google Scholar 

  • Argyrou A, Jin L, Siconilfi-Baez L, Angeletti RH, Blanchard JS (2006) Proteome-wide profiling of isoniazid targets in mycobacterium tuberculosis. Biochemistry 45:13947–13953

    Article  PubMed  CAS  Google Scholar 

  • Bailey DM, Hansen PE, Hlavac AG, Baizman ER, Pearl J, Defelice AF, Feigenson ME (1985) 3,4-Diphenyl-1H-pyrazole-1-propanamine antidepressants. J Med Chem 28:256–260

    Article  PubMed  CAS  Google Scholar 

  • Cheng H, Lundy DeMello KM, Li J, Sakya SM, Ando K, Kawamura K, Kato T, Rafka RJ, Jaynes BH, Ziegler CB, Stevens R, Lund LA, Mann DW, Kilroy C, Haven ML, Nimz EL, Dutra JK, Li C, Minich ML, Kolosko NL, Petras C, Silivia AM, Seibel SB (2006) Synthesis and SAR of heteroaryl-phenyl-substituted pyrazole derivatives as highly selective and potent canine COX-2 inhibitors. Bioorg Med Chem Lett 16:2076

    Article  PubMed  CAS  Google Scholar 

  • Chowdhury MA, Abdellatif KRA, Dong Y, Das D, Suresh MR, Knaus EE (2008) Synthesis of celecoxib analogs that possess a N-hydroxypyrid-2(1H)one 5-lipoxygenase pharmacophore: Biological evaluation as dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity. Bioorg Med Chem Lett 18:6138–6141

    Article  PubMed  CAS  Google Scholar 

  • Daffé M, Draper P (1998) The envelope layers of mycobacteria with reference to their pathogenicity. Adv Microb Physiol 39:131–203

    Article  PubMed  Google Scholar 

  • Delaine T, Genisson VB, Meunier B, Bernadou J (2007) Synthesis of the isonicotinoylnicotinamide scaffolds of the naturally occurring isoniazid−NAD(P) adducts. J Org Chem 72:675–678

    Article  PubMed  CAS  Google Scholar 

  • Foye WO, Lemke TL, Williams DA (1995) Principles of medicinal chemistry, 4th edn. B.I. Waverly Pvt Ltd, New Delhi, pp 768–769, 806–811

  • Jagrat M, Behera J, Yabanoglu S, Ercan A, Ucar G, Sinha BN, Sankaran V, Basu A, Jayaprakash V (2011) Pyrazoline based MAO inhibitors: synthesis, biological evaluation and SAR studies. Bioorg Med Chem Lett. doi:10.1016/j.bmcl.2011.05.057

    PubMed  Google Scholar 

  • Janus SL, Magdif AZ, Erik BP, Claus N (1999) Synthesis of triazenopyrazole derivatives as potential inhibitors of HIV-1. Monatsh Chem 130:1167–1173

    Google Scholar 

  • Jeong TS, Kim KS, Kim JR, Cho KY, Lee S (2004) Novel 3,5-diaryl pyrazolines and pyrazole as low-density lipoprotein (LDL) oxidation inhibitor. Bioorg Med Chem Lett 14:2719–2723

    Article  PubMed  CAS  Google Scholar 

  • Johnsson K, King DS, Schultz PG (1995) Studies on the mechanism of action of isoniazid and ethionamide in the chemotherapy of tuberculosis. J Am Chem Soc 117:5009–5010

    Article  CAS  Google Scholar 

  • Kumar P (2009) Solid state oxidative aromatization of Hantzsch 1,4-dihydropyridines to pyridines using iodobenzene diacetate or hydroxy(tosyloxy)iodobenzene. Chin J Chem 27:1487–1491

    Article  CAS  Google Scholar 

  • Kumar P, Kumar A (2010) An expeditious synthesis of isoxazoline using cetyltrimethylammonium cerium nitrate: a phase transferring oxidative 1,3-dipolar cycloaddition. Chin Chem Lett 21:1287–1290

    Article  CAS  Google Scholar 

  • Kumar A, Chawla A, Jain S, Kumar P, Kumar S (2011a) 3-Aryl-2-{4-[4-(2,4-dioxothiazolidin-5-ylmethyl)phenoxy]-phenyl}-acrylic acid alkyl ester: synthesis and antihyperglycemic evaluation. Med Chem Res 20:678–686

    Article  CAS  Google Scholar 

  • Kumar P, Kumar S, Husain K, Kumar A (2011b) An efficient synthesis of pyrazole chalcones under solvent free conditions at room temperature. Chin Chem Lett 22:37–40

    Article  CAS  Google Scholar 

  • Lorian V (1986) Antibiotics in laboratory medicine, 2nd edn. Williams & Wilkins, London, p 116

    Google Scholar 

  • Manna K, Agrawal YK (2009) Microwave assisted synthesis of new indophenazine 1,3,5-trisubstruted pyrazoline derivatives of benzofuran and their antimicrobial activity. Bio Med Chem Lett 19:2688–2692

    Article  CAS  Google Scholar 

  • Marrakchi H, Laneelle G, Quémard A (2000) InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II. Microbiology 146:289–296

    PubMed  CAS  Google Scholar 

  • McFarland J (1907) Nephelometer: an instrument for estimating the number of bacteria in suspension used for calculating the opsonic index and for vaccines. J Am Med Assoc 49:1176–1178

    Article  Google Scholar 

  • Michon V, Du Penhoat CH, Tombret F, Gillardin JM, Lepagez F, Berthon L (1995) Preparation, structural analysis and anticonvulsant activity of 3- and 5-aminopyrazole N-benzoyl derivatives. Eur J Med Chem 30:147–155

    Article  CAS  Google Scholar 

  • NCCLS (2000) Method for dilution antimicrobial susceptibility test for bacteria that grow aerobically approved standard, 5th edn. National Committee for Clinical Laboratory Standards, Villanova, PA

    Google Scholar 

  • Nguyen M, Claparols C, Bernadou J, Meunier B (2002) Is the isonicotinoyl radical generated during activation of isoniazid by MnIII-pyrophosphate? C. R. Chimie 5:325–330

    Article  CAS  Google Scholar 

  • Ozdemir Z, Kandilci HB, Gumusel B, Alıs UC, Bilgin AA (2007) Synthesis and studies on antidepressant and anticonvulsant activities of some 3-(2-furyl)-pyrazoline derivatives. Eur J Med Chem 42:373–379

    Article  PubMed  Google Scholar 

  • Prasad YR, Rao AL, Prasoona L, Murali K, Kumar PR (2005) Synthesis and antidepressant activity of some 1,3,5-triphenyl-2-pyrazolines and 3-(2″-hydroxy naphthalen-1″-yl)-1,5-diphenyl-2-pyrazolines. Bioorg Med Chem Lett 15:5030–5034

    Article  CAS  Google Scholar 

  • Quémard A, Dessen A, Sugantino M, Jacobs WR Jr, Sacchetini JC, Blanchard JS (1996) Binding of catalase-peroxidase-activated isoniazid to wild-type and mutant mycobacterium tuberculosis enoyl-ACP reductases. J Am Chem Soc 118:1561–1562

    Article  Google Scholar 

  • Shaharyar M, Abdullah MM, Bakht MA, Majeed J (2010) Pyrazoline bearing benzimidazoles: search for anticancer agent. Eur J Med Chem 45:114–119

    Article  PubMed  CAS  Google Scholar 

  • Sharma PK, Kumar S, Kumar P, Kaushik P, Kaushik D, Dhingra Y, Aneja KR (2010) Synthesis and biological evaluation of some pyrazolylpyrazolines as anti-inflammatory-antimicrobial agents. Eur J Med Chem 45:2650–2655

    Article  PubMed  CAS  Google Scholar 

  • Sridhar R, Perumal PT, Etti S, Shanmugam G, Ponnuswamy MN, Prabavathy VR, Mathivanan N (2004) Design, synthesis and anti-microbial activity of 1H-pyrazole carboxylates. Bioorg Med Chem Lett 14:6035–6040

    Article  PubMed  CAS  Google Scholar 

  • Sriram D, Yogeeshwari P (2008) Medicinal chemistry, 2nd edn. Pearson Education, Dorling Kindersley, Noida, pp 329–333

    Google Scholar 

  • Tewari AK, Mishra A (2001) Synthesis and anti-inflammatory activities of N4,N5-disubstituted-3-methyl-1H-pyrazolo[3,4-c]pyridazines. Bioorg Med Chem 9:715

    Article  PubMed  CAS  Google Scholar 

  • Turan-Zitouni G, Chevallet P, Kilic FS, Erol K (2000) Synthesis of some thiazolyl-pyrazoline derivatives and preliminary investigation of their hypotensive activity. Eur J Med Chem 35:635–641

    Article  PubMed  CAS  Google Scholar 

  • Wiley RH, Wiley P (1964) Pyrazolones, pyrazolidones and derivatives. Wiley, New York

    Google Scholar 

  • Xia Y, Dong ZW, Zhao BX, Ge X, Meng N, Shin DS, Miao JY (2007) Synthesis and structure–activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide derivatives as potential agents against A549 lung cancer cells. Bioorg Med Chem 15:6893–6899

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Financial support by UGC, New Delhi, is gratefully acknowledged. Thanks to Mr Ashwani Kumar, GJUST-Hisar, for his valuable suggestions for carrying out antimicrobial activity.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Parvin Kumar.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 736 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kumar, S., Meenakshi, Kumar, S. et al. Synthesis and antimicrobial activity of some (3-phenyl-5-(1-phenyl-3-aryl-1H-pyrazol-4-yl)-4,5-dihydro-1H-pyrazol-1-yl)(pyridin-4-yl)methanones: new derivatives of 1,3,5-trisubstituted pyrazolines. Med Chem Res 22, 433–439 (2013). https://doi.org/10.1007/s00044-012-0045-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-012-0045-7

Keywords

Navigation